REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 176 participants.

Also called NCT07157384

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 176 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07157384
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07157384. Randomized; no masking; primary purpose treatment. Start 2025-09 (anticipated); primary completion 2027-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education
Acronym
REMIT2D isCGM
Intervention (Dietary supplement)
Low calorie meal replacement plan
Intervention (Behavioral)
Diabetes self management education
Intervention (Device)
Intermittently scanned continuous glucose monitoring
Intervention (Device)
capillary blood glucose monitoring
Lead sponsor
LMC Diabetes & Endocrinology Ltd. (class: other)
Collaborator
Abbott Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct07157384
Content hash
f815b6cb00d6be1e678444b85195db7c04001f473d686652d667a0af4ff614dd